Loading...

Biotin anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Biotin_042706
C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
  • M1slash70_Biotin_042706
    C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
Compare all formats
Cat # Size Price Save
101203 50 µg ¥7,480
101204 500 µg ¥23,100
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  3. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  4. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  5. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  6. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  7. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  8. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  9. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  10. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  11. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  12. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  13. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  14. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  15. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  16. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  17. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  18. Li S, et al. 2022. Elife. 11:. PubMed
  19. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  20. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  21. García-Hernández ML, et al. 2022. Front Immunol. 13:1026574. PubMed
  22. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  23. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  24. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  25. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  26. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  27. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  28. Wang Y, et al. 2022. Front Immunol. 12:809896. PubMed
  29. Yokozeki Y, et al. 2021. BMC Musculoskelet Disord. 22:634. PubMed
  30. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  31. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  32. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  33. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  34. Thierry GR, et al. 2018. J Exp Med. 215:2972. PubMed
  35. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  36. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  37. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  38. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  39. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  40. Chou H, et al. 2011. Hepatology. 53:1007. PubMed
  41. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  42. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  43. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  44. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  45. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  46. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  47. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  48. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  49. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  50. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  51. Periasamy S, et al. 2016. PLoS Pathog. 12: 1005517. PubMed
  52. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  53. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  54. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  55. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  56. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  57. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  58. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  59. Bian Y, et al. 2017. PLoS Pathog. 13:e1006384. PubMed
  60. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  61. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  62. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  63. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  64. Ben C, et al. 2020. J Biol Chem. 295:13965. PubMed
  65. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  66. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  67. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  68. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  69. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  70. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  71. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  72. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  73. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  74. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  75. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  76. Köchl R, et al. 2020. Elife. 9:00. PubMed
  77. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  78. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  79. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  80. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  81. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  82. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  83. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  84. Vural A, et al. 2019. J Immunol. 202:1510. PubMed
  85. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  86. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  87. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  88. Carr M, et al. 2016. Proc Natl Acad Sci U S A. 113(52):15024-15029. PubMed
  89. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  90. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  91. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  92. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  93. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  94. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  95. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  96. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  97. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  98. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  99. Leyva‐Castillo JM et al. 2019. Immunity. 50(5):1262-1275 . PubMed
  100. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  101. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  102. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  103. Liu G, et al. 2022. Ann Transl Med. 10:693. PubMed
  104. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  105. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  106. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  107. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  108. Stofkova A, et al. 2021. Int J Mol Sci. 23:. PubMed
  109. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  110. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  111. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  112. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  113. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  114. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  115. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  116. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  117. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  118. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  119. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  120. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  121. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  122. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  123. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  124. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  125. Chen Z, et al. 2020. Cell Death Dis. 11:180. PubMed
  126. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  127. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  128. Koide S, et al. 2022. iScience. 25:103603. PubMed
  129. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  130. Rohrbeck L, et al. 2020. Immunol Cell Biol. . PubMed
  131. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  132. De Micheli AJ, et al. 2020. Cell Rep. 30:3583. PubMed
  133. Stofkova A, et al. 2019. Sci Rep. 2.009027778. PubMed
  134. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  135. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  136. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  137. Ma C, et al. 2021. J Exp Med. :218. PubMed
  138. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  139. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  140. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  141. Yrlid U, et al. 2019. J Leukoc Biol. 105:195. PubMed
  142. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  143. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  144. Teng Y, et al. 2021. Mol Ther. 29:2424. PubMed
  145. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  146. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  147. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  148. Young K, et al. 2021. Cell Stem Cell. . PubMed
  149. Frohlich J, et al. 2020. Aging (Albany NY). 12:20024. PubMed
  150. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_312787 (BioLegend Cat. No. 101203)
AB_312787 (BioLegend Cat. No. 101204)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account